|
ROSE12 Clinical Trials
1 actively recruiting trial across 1 location
No change since July 2026
Philadelphia, Pennsylvania1 trial
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
University of Pennsylvania Perelman Center for Advanced Medicine
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.